Advanced Search (OLGA)

Gene: PCDH10 (protocadherin 10) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

PCDH10

Name:

protocadherin 10

RGD ID:

1348202

HGNC Page

HGNC:13404

Description:

Predicted to enable calcium ion binding activity. Predicted to be involved in cell adhesion. Predicted to act upstream of or within homophilic cell adhesion via plasma membrane adhesion molecules. Predicted to be located in membrane. Predicted to be active in glutamatergic synapse and postsynaptic membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

DKFZp761O2023; KIAA1400; MGC133344; OL-PCDH; ortholog of OL-pcdh; PCDH19; protocadherin-10

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	4	133,149,294 - 133,208,606 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	4	133,149,294 - 133,208,606 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	4	134,070,449 - 134,115,855 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	4	134,289,920 - 134,332,182 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	4	134,428,074 - 134,470,336	NCBI
Celera	4	131,409,480 - 131,451,744 (+)	NCBI		Celera
Cytogenetic Map	4	q28.3	NCBI
HuRef	4	129,799,227 - 129,841,484 (+)	NCBI		HuRef
CHM1_1	4	134,046,945 - 134,089,210 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	4	136,472,535 - 136,531,845 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PCDH10	Human	autistic disorder		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:18621663

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PCDH10	Human	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		6480464	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PCDH10 mRNA	CTD	PMID:22079256
PCDH10	Human	17alpha-ethynylestradiol	increases expression	ISO	RGD:1565811	6480464	Ethinyl Estradiol results in increased expression of PCDH10 mRNA	CTD	PMID:29097150
PCDH10	Human	17beta-estradiol	decreases expression	EXP		6480464	Estradiol results in decreased expression of PCDH10 mRNA	CTD	PMID:21185374\|PMID:31614463
PCDH10	Human	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		6480464	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of PCDH10 mRNA	CTD	PMID:36804509
PCDH10	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557192	6480464	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PCDH10 promoter]	CTD	PMID:19654925
PCDH10	Human	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1565811	6480464	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PCDH10 mRNA	CTD	PMID:32109520
PCDH10	Human	2,4-D	multiple interactions	ISO	RGD:1557192	6480464	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ...	CTD	PMID:37567420
PCDH10	Human	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1557192	6480464	tetrabromobisphenol A results in decreased expression of PCDH10 mRNA	CTD	PMID:25172293
PCDH10	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557192	6480464	bisphenol S results in increased expression of PCDH10 mRNA	CTD	PMID:30951980
PCDH10	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1565811	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
PCDH10	Human	aflatoxin B1	decreases methylation	EXP		6480464	Aflatoxin B1 results in decreased methylation of PCDH10 gene	CTD	PMID:27153756
PCDH10	Human	aldehydo-D-glucose	multiple interactions	ISO	RGD:1557192	6480464	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ...	CTD	PMID:37567420
PCDH10	Human	all-trans-retinoic acid	increases expression	EXP		6480464	Tretinoin results in increased expression of PCDH10 mRNA	CTD	PMID:21934132
PCDH10	Human	all-trans-retinoic acid	multiple interactions	ISO	RGD:1557192	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCDH10 mRNA	CTD	PMID:36189433
PCDH10	Human	arsane	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	arsenic atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	arsenite(3-)	multiple interactions	EXP		6480464	arsenite promotes the reaction [G3BP1 protein binds to PCDH10 mRNA]	CTD	PMID:32406909
PCDH10	Human	belinostat	increases expression	EXP		6480464	belinostat results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	belinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
PCDH10	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of PCDH10 exon	CTD	PMID:27901495
PCDH10	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of PCDH10 promoter	CTD	PMID:27901495
PCDH10	Human	bisphenol A	decreases expression	ISO	RGD:1565811	6480464	bisphenol A results in decreased expression of PCDH10 mRNA	CTD	PMID:25181051
PCDH10	Human	bisphenol A	multiple interactions	ISO	RGD:1565811	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
PCDH10	Human	bisphenol A	decreases expression	ISO	RGD:1557192	6480464	bisphenol A results in decreased expression of PCDH10 mRNA	CTD	PMID:32156529
PCDH10	Human	bisphenol A	increases expression	ISO	RGD:1565811	6480464	bisphenol A results in increased expression of PCDH10 mRNA	CTD	PMID:29097150
PCDH10	Human	bisphenol F	multiple interactions	ISO	RGD:1565811	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
PCDH10	Human	C60 fullerene	decreases expression	ISO	RGD:1565811	6480464	fullerene C60 results in decreased expression of PCDH10 mRNA	CTD	PMID:19167457
PCDH10	Human	choline	multiple interactions	ISO	RGD:1557192	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ...	CTD	PMID:20938992
PCDH10	Human	clobetasol	decreases expression	ISO	RGD:1557192	6480464	Clobetasol results in decreased expression of PCDH10 mRNA	CTD	PMID:27462272
PCDH10	Human	cobalt dichloride	decreases expression	EXP		6480464	cobaltous chloride results in decreased expression of PCDH10 mRNA	CTD	PMID:19320972
PCDH10	Human	coumestrol	decreases expression	EXP		6480464	Coumestrol results in decreased expression of PCDH10 mRNA	CTD	PMID:19167446
PCDH10	Human	Cytochalasin H	increases expression	EXP		6480464	cytochalasin H results in increased expression of PCDH10 mRNA	CTD	PMID:30507090
PCDH10	Human	D-glucose	multiple interactions	ISO	RGD:1557192	6480464	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ...	CTD	PMID:37567420
PCDH10	Human	dioxygen	increases expression	EXP		6480464	Oxygen deficiency results in increased expression of PCDH10 mRNA	CTD	PMID:24236059
PCDH10	Human	disodium selenite	decreases expression	ISO	RGD:1557192	6480464	Sodium Selenite results in decreased expression of PCDH10 mRNA	CTD	PMID:23274088
PCDH10	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
PCDH10	Human	endosulfan	increases expression	ISO	RGD:1565811	6480464	Endosulfan results in increased expression of PCDH10 mRNA	CTD	PMID:29391264
PCDH10	Human	entinostat	increases expression	EXP		6480464	entinostat results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	entinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
PCDH10	Human	ethanol	increases expression	ISO	RGD:1557192	6480464	Ethanol results in increased expression of PCDH10 mRNA	CTD	PMID:30319688
PCDH10	Human	ethanol	affects splicing	ISO	RGD:1557192	6480464	Ethanol affects the splicing of PCDH10 mRNA	CTD	PMID:30319688
PCDH10	Human	folic acid	multiple interactions	ISO	RGD:1557192	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ...	CTD	PMID:20938992
PCDH10	Human	fructose	multiple interactions	ISO	RGD:1557192	6480464	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ...	CTD	PMID:37567420
PCDH10	Human	genistein	increases expression	ISO	RGD:1557192	6480464	Genistein results in increased expression of PCDH10 mRNA	CTD	PMID:32186404
PCDH10	Human	gentamycin	increases expression	ISO	RGD:1565811	6480464	Gentamicins results in increased expression of PCDH10 mRNA	CTD	PMID:33387578
PCDH10	Human	glucose	multiple interactions	ISO	RGD:1557192	6480464	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose more ...	CTD	PMID:37567420
PCDH10	Human	L-methionine	multiple interactions	ISO	RGD:1557192	6480464	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ...	CTD	PMID:20938992
PCDH10	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH10 mRNA	CTD	PMID:35811015
PCDH10	Human	manganese atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	manganese(0)	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	manganese(II) chloride	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	mercury dibromide	increases expression	EXP		6480464	mercuric bromide results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	mercury dibromide	multiple interactions	EXP		6480464	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
PCDH10	Human	methylisothiazolinone	increases expression	EXP		6480464	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH10 mRNA	CTD	PMID:31629900
PCDH10	Human	methylmercury chloride	increases expression	EXP		6480464	methylmercuric chloride results in increased expression of PCDH10 mRNA	CTD	PMID:28001369
PCDH10	Human	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1557192	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PCDH10 mRNA	CTD	PMID:36189433
PCDH10	Human	p-chloromercuribenzoic acid	increases expression	EXP		6480464	p-Chloromercuribenzoic Acid results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	panobinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
PCDH10	Human	panobinostat	increases expression	EXP		6480464	panobinostat results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	paracetamol	increases expression	ISO	RGD:1565811	6480464	Acetaminophen results in increased expression of PCDH10 mRNA	CTD	PMID:33387578
PCDH10	Human	phenylmercury acetate	increases expression	EXP		6480464	Phenylmercuric Acetate results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
PCDH10	Human	pirinixic acid	increases expression	ISO	RGD:1557192	6480464	pirinixic acid results in increased expression of PCDH10 mRNA	CTD	PMID:20813756
PCDH10	Human	potassium chromate	multiple interactions	EXP		6480464	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PCDH10 mRNA	CTD	PMID:22079256
PCDH10	Human	potassium chromate	increases expression	EXP		6480464	potassium chromate(VI) results in increased expression of PCDH10 mRNA	CTD	PMID:22079256
PCDH10	Human	Ptaquiloside	decreases expression	ISO	RGD:1557192	6480464	ptaquiloside results in decreased expression of PCDH10 mRNA	CTD	PMID:23274088
PCDH10	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PCDH10 mRNA	CTD	PMID:23557933
PCDH10	Human	rotenone	decreases expression	EXP		6480464	Rotenone results in decreased expression of PCDH10 mRNA	CTD	PMID:29955902
PCDH10	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH10 mRNA	CTD	PMID:35811015
PCDH10	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386
PCDH10	Human	silver atom	decreases expression	ISO	RGD:1557192	6480464	Silver results in decreased expression of PCDH10 mRNA	CTD	PMID:27131904
PCDH10	Human	silver(0)	decreases expression	ISO	RGD:1557192	6480464	Silver results in decreased expression of PCDH10 mRNA	CTD	PMID:27131904
PCDH10	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of PCDH10 mRNA	CTD	PMID:22714537
PCDH10	Human	sodium arsenite	decreases expression	ISO	RGD:1557192	6480464	sodium arsenite results in decreased expression of PCDH10 mRNA	CTD	PMID:36209798
PCDH10	Human	sodium arsenite	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
PCDH10	Human	sulforaphane	decreases expression	EXP		6480464	sulforaphane results in decreased expression of PCDH10 mRNA	CTD	PMID:31838189
PCDH10	Human	temozolomide	increases expression	EXP		6480464	Temozolomide results in increased expression of PCDH10 mRNA	CTD	PMID:31758290
PCDH10	Human	testosterone	increases expression	EXP		6480464	Testosterone results in increased expression of PCDH10 mRNA	CTD	PMID:33359661
PCDH10	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of PCDH10 mRNA	CTD	PMID:38568856
PCDH10	Human	titanium dioxide	increases methylation	ISO	RGD:1557192	6480464	titanium dioxide results in increased methylation of PCDH10 gene	CTD	PMID:35295148
PCDH10	Human	trichostatin A	increases expression	EXP		6480464	trichostatin A results in increased expression of PCDH10 mRNA	CTD	PMID:24935251\|PMID:26272509\|PMID:26705709
PCDH10	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
PCDH10	Human	triptonide	increases expression	ISO	RGD:1557192	6480464	triptonide results in increased expression of PCDH10 mRNA	CTD	PMID:33045310
PCDH10	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of PCDH10 mRNA	CTD	PMID:19101580\|PMID:23179753\|PMID:24383497\|PMID:24935251\|PMID:26272509\|PMID:28001369
PCDH10	Human	valproic acid	multiple interactions	EXP		6480464	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
PCDH10	Human	vorinostat	increases expression	EXP		6480464	vorinostat results in increased expression of PCDH10 mRNA	CTD	PMID:26272509
PCDH10	Human	vorinostat	multiple interactions	EXP		6480464	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...	CTD	PMID:27188386

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PCDH10	Human	cell adhesion	involved_in	IEA	UniProtKB-KW:KW-0130	150520179		UniProt	GO_REF:0000043
PCDH10	Human	cell adhesion	involved_in	IEA	InterPro:IPR020894	150520179		InterPro	GO_REF:0000002
PCDH10	Human	cell adhesion	acts_upstream_of_or_within	IEA	UniProtKB:E9PXQ7\|ensembl:ENSMUSP00000131073	150520179		Ensembl	GO_REF:0000107
PCDH10	Human	cell adhesion	involved_in	IBA	MGI:106671\|MGI:1298369\|MGI:1338042\|MGI:1855700\|MGI:2136740\|MGI:2684924\|PANTHER:PTN001932250\|RGD:620504\|UniProtKB:A0A8J1ME87\|UniProtKB:Q9HBB8\|ZFIN:ZDB-GENE-000607-1\|ZFIN:ZDB-GENE-030131-4218	150520179		GO_Central	GO_REF:0000033
PCDH10	Human	homophilic cell adhesion via plasma membrane adhesion molecules	involved_in	IEA	InterPro:IPR002126	150520179		InterPro	GO_REF:0000002
PCDH10	Human	homophilic cell adhesion via plasma membrane adhesion molecules	acts_upstream_of_or_within	IEA	UniProtKB:E9PXQ7\|ensembl:ENSMUSP00000131073	150520179		Ensembl	GO_REF:0000107
PCDH10	Human	nervous system development	involved_in	IEA	ARBA:ARBA00027428	150520179		UniProt	GO_REF:0000117

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PCDH10	Human	glutamatergic synapse	is_active_in	IEA	UniProtKB:E9PXQ7\|ensembl:ENSMUSP00000131073	150520179		Ensembl	GO_REF:0000107
PCDH10	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
PCDH10	Human	membrane	located_in	IEA	InterPro:IPR002126\|InterPro:IPR015919	150520179		InterPro	GO_REF:0000002
PCDH10	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
PCDH10	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
PCDH10	Human	plasma membrane	is_active_in	IBA	MGI:106671\|MGI:1298369\|MGI:1338042\|MGI:1891428\|MGI:2136740\|MGI:2136752\|MGI:2157782\|MGI:2684924\|PANTHER:PTN001932250\|RGD:1306348\|RGD:69350\|UniProtKB:O60245\|UniProtKB:Q9HBB8\|WB:WBGene00000395\|ZFIN:ZDB-GENE-000607-1\|ZFIN:ZDB-GENE-030131-4218	150520179		GO_Central	GO_REF:0000033
PCDH10	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
PCDH10	Human	plasma membrane	located_in	IEA	InterPro:IPR020894	150520179		InterPro	GO_REF:0000002
PCDH10	Human	postsynaptic membrane	is_active_in	IEA	UniProtKB:E9PXQ7\|ensembl:ENSMUSP00000131073	150520179		Ensembl	GO_REF:0000107

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PCDH10	Human	calcium ion binding	enables	IEA	UniRule:UR000413450	150520179		UniProt	GO_REF:0000104
PCDH10	Human	calcium ion binding	enables	IEA	InterPro:IPR002126\|InterPro:IPR015919	150520179		InterPro	GO_REF:0000002

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8012384	PMID:10380929	PMID:10716726	PMID:10718198	PMID:10817752	PMID:10835267	PMID:11230163	PMID:11549318	PMID:12477932	PMID:16247458	PMID:16344560	PMID:18621663
PMID:18644894	PMID:19084528	PMID:19262141	PMID:19681120	PMID:19709077	PMID:20353276	PMID:20379614	PMID:21237250	PMID:21314642	PMID:21597995	PMID:21873635	PMID:21960365
PMID:22206871	PMID:22245948	PMID:22543497	PMID:23171734	PMID:23180019	PMID:23260144	PMID:23321168	PMID:23321465	PMID:23569128	PMID:23839493	PMID:23929756	PMID:24309322
PMID:24406169	PMID:24722188	PMID:24740680	PMID:25085246	PMID:25086586	PMID:25260683	PMID:25590240	PMID:26081897	PMID:26276761	PMID:26406945	PMID:26679037	PMID:26871474
PMID:26881880	PMID:26927373	PMID:26970279	PMID:27338109	PMID:27609421	PMID:27659532	PMID:28498423	PMID:28514442	PMID:29202805	PMID:29676528	PMID:30213786	PMID:31088413
PMID:31210316	PMID:31651684	PMID:31871319	PMID:32535594	PMID:33271263	PMID:33306668	PMID:33527791	PMID:33961781	PMID:35844135	PMID:36538983	PMID:37058252	PMID:37147733
PMID:38569033	PMID:39048821

PCDH10
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	4	133,149,294 - 133,208,606 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	4	133,149,294 - 133,208,606 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	4	134,070,449 - 134,115,855 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	4	134,289,920 - 134,332,182 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	4	134,428,074 - 134,470,336	NCBI
Celera	4	131,409,480 - 131,451,744 (+)	NCBI		Celera
Cytogenetic Map	4	q28.3	NCBI
HuRef	4	129,799,227 - 129,841,484 (+)	NCBI		HuRef
CHM1_1	4	134,046,945 - 134,089,210 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	4	136,472,535 - 136,531,845 (+)	NCBI		T2T-CHM13v2.0

Pcdh10
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	3	45,332,833 - 45,389,014 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	3	45,332,833 - 45,390,058 (+)	Ensembl		GRCm39 Ensembl
GRCm38	3	45,378,398 - 45,434,579 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	3	45,378,398 - 45,435,623 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	3	45,182,320 - 45,238,501 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	3	45,474,806 - 45,479,230 (+)	NCBI		MGSCv36	mm8
Celera	3	45,037,595 - 45,093,756 (+)	NCBI		Celera
Cytogenetic Map	3	B	NCBI
cM Map	3	20.35	NCBI

Pcdh10
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	2	130,553,432 - 130,619,591 (+)	NCBI		GRCr8
mRatBN7.2	2	128,617,212 - 128,683,354 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	2	128,617,174 - 128,677,190 (+)	Ensembl		mRatBN7.2 Ensembl
Rnor_6.0	2	136,992,355 - 137,017,705 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	2	136,993,208 - 137,014,492 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	2	156,481,902 - 156,505,195 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	2	132,890,164 - 132,932,966 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	2	126,100,636 - 126,125,570 (+)	NCBI		Celera
Cytogenetic Map	2	q26	NCBI

Pcdh10
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955428	9,433,478 - 9,495,305 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955428	9,433,478 - 9,495,260 (-)	NCBI	ChiLan1.0	ChiLan1.0

PCDH10
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	3	130,961,798 - 131,020,265 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	4	131,357,352 - 131,416,321 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	4	125,460,202 - 125,519,514 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	4	136,708,715 - 136,753,987 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	4	136,709,572 - 136,722,801 (+)	Ensembl	panpan1.1		panPan2

PCDH10
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	19	8,671,750 - 8,732,663 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	19	8,691,727 - 8,731,690 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	19	8,845,071 - 8,906,078 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	19	8,734,170 - 8,795,507 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	19	8,734,589 - 8,794,538 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	19	8,657,959 - 8,718,822 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	19	9,018,006 - 9,078,894 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	19	9,453,748 - 9,515,017 (-)	NCBI		UU_Cfam_GSD_1.0

Pcdh10
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405301	57,631,764 - 57,693,436 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936681	1,002,166 - 1,040,392 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936681	1,001,223 - 1,058,628 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

PCDH10
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	8	93,002,562 - 93,046,693 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	8	93,023,079 - 93,047,265 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	8	99,226,414 - 99,230,427 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

PCDH10
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	7	80,184,414 - 80,227,184 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	7	80,184,388 - 80,225,757 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666037	59,460,966 - 59,524,125 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Pcdh10
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624777	13,693,873 - 13,747,830 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624777	13,693,964 - 13,747,504 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in PCDH10
82 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 4q28.2-31.21(chr4:128119872-142431375)x1	copy number loss	See cases [RCV000051056]	Chr4:128119872..142431375 [GRCh38] Chr4:129041027..143352528 [GRCh37] Chr4:129260477..143571978 [NCBI36] Chr4:4q28.2-31.21	pathogenic
GRCh38/hg38 4q26-35.2(chr4:118065569-190042639)x3	copy number gain	See cases [RCV000051785]	Chr4:118065569..190042639 [GRCh38] Chr4:118986724..190828225 [GRCh37] Chr4:119206172..191200788 [NCBI36] Chr4:4q26-35.2	pathogenic
GRCh38/hg38 4q27-35.2(chr4:121518223-190062270)x3	copy number gain	See cases [RCV000051786]	Chr4:121518223..190062270 [GRCh38] Chr4:122439378..190828225 [GRCh37] Chr4:122658828..191220419 [NCBI36] Chr4:4q27-35.2	pathogenic
GRCh38/hg38 4q22.2-32.3(chr4:92913386-165299707)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051775]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051775]\|See cases [RCV000051775]	Chr4:92913386..165299707 [GRCh38] Chr4:93834537..166220859 [GRCh37] Chr4:94053560..166440309 [NCBI36] Chr4:4q22.2-32.3	pathogenic
GRCh38/hg38 4q22.3-28.3(chr4:96092893-136410207)x3	copy number gain	See cases [RCV000051776]	Chr4:96092893..136410207 [GRCh38] Chr4:97014044..137331362 [GRCh37] Chr4:97233067..137550812 [NCBI36] Chr4:4q22.3-28.3	pathogenic
GRCh38/hg38 4q26-31.21(chr4:116630862-145429900)x1	copy number loss	See cases [RCV000053321]	Chr4:116630862..145429900 [GRCh38] Chr4:117552018..146351052 [GRCh37] Chr4:117771466..146570502 [NCBI36] Chr4:4q26-31.21	pathogenic
NM_020815.2(PCDH10):c.266C>T (p.Pro89Leu)	single nucleotide variant	Malignant melanoma [RCV000066274]	Chr4:133150406 [GRCh38] Chr4:134071561 [GRCh37] Chr4:134291011 [NCBI36] Chr4:4q28.3	not provided
GRCh38/hg38 4q28.3-35.2(chr4:131985253-190095391)x3	copy number gain	See cases [RCV000137721]	Chr4:131985253..190095391 [GRCh38] Chr4:132906408..190828225 [GRCh37] Chr4:133125858..191250527 [NCBI36] Chr4:4q28.3-35.2	pathogenic\|likely benign
GRCh38/hg38 4q28.1-35.1(chr4:125432943-185761887)x3	copy number gain	See cases [RCV000138578]	Chr4:125432943..185761887 [GRCh38] Chr4:126354098..186683041 [GRCh37] Chr4:126573548..186920035 [NCBI36] Chr4:4q28.1-35.1	pathogenic\|likely benign
GRCh38/hg38 4q26-28.3(chr4:117351881-133565667)x1	copy number loss	See cases [RCV000143207]	Chr4:117351881..133565667 [GRCh38] Chr4:118273037..134486822 [GRCh37] Chr4:118492485..134706272 [NCBI36] Chr4:4q26-28.3	pathogenic
GRCh37/hg19 4q26-35.2(chr4:119437495-190904301)x3	copy number gain	See cases [RCV000240392]	Chr4:119437495..190904301 [GRCh37] Chr4:4q26-35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:12440-190904441)x3	copy number gain	See cases [RCV000446653]	Chr4:12440..190904441 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)	copy number gain	See cases [RCV000510453]	Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4q25-35.2(chr4:109199664-189752726)x3	copy number gain	See cases [RCV000511945]	Chr4:109199664..189752726 [GRCh37] Chr4:4q25-35.2	pathogenic
GRCh37/hg19 4q22.1-35.2(chr4:93071152-190957473)x3	copy number gain	See cases [RCV000510970]	Chr4:93071152..190957473 [GRCh37] Chr4:4q22.1-35.2	pathogenic
NM_032961.3(PCDH10):c.1785G>T (p.Glu595Asp)	single nucleotide variant	not specified [RCV004308922]	Chr4:133151925 [GRCh38] Chr4:134073080 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4p16.3-q35.2(chr4:68346-190957473)x3	copy number gain	See cases [RCV000512241]	Chr4:68346..190957473 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
Single allele	deletion	not provided [RCV000678021]	Chr4:126549693..141313049 [GRCh37] Chr4:4q28.1-31.1	pathogenic
GRCh37/hg19 4q28.3(chr4:132890351-135831973)x3	copy number gain	not provided [RCV000682458]	Chr4:132890351..135831973 [GRCh37] Chr4:4q28.3	likely benign\|uncertain significance
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190915650)x3	copy number gain	not provided [RCV000743155]	Chr4:49450..190915650 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:49450-190963766)x3	copy number gain	not provided [RCV000743156]	Chr4:49450..190963766 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
GRCh37/hg19 4p16.3-q35.2(chr4:11525-191028879)x3	copy number gain	not provided [RCV000743147]	Chr4:11525..191028879 [GRCh37] Chr4:4p16.3-q35.2	pathogenic
NM_032961.3(PCDH10):c.1290C>A (p.Thr430=)	single nucleotide variant	not provided [RCV000916708]	Chr4:133151430 [GRCh38] Chr4:134072585 [GRCh37] Chr4:4q28.3	benign
NM_032961.3(PCDH10):c.2690+9T>C	single nucleotide variant	not provided [RCV000977784]	Chr4:133154374 [GRCh38] Chr4:134075529 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.2013C>G (p.Thr671=)	single nucleotide variant	not provided [RCV000919416]	Chr4:133152153 [GRCh38] Chr4:134073308 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.570C>T (p.Asp190=)	single nucleotide variant	not provided [RCV000906716]	Chr4:133150710 [GRCh38] Chr4:134071865 [GRCh37] Chr4:4q28.3	benign
NM_032961.3(PCDH10):c.978G>A (p.Val326=)	single nucleotide variant	not provided [RCV000904435]	Chr4:133151118 [GRCh38] Chr4:134072273 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.2411T>C (p.Ile804Thr)	single nucleotide variant	not provided [RCV000954629]	Chr4:133152551 [GRCh38] Chr4:134073706 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.529G>A (p.Gly177Ser)	single nucleotide variant	not specified [RCV004309832]	Chr4:133150669 [GRCh38] Chr4:134071824 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4q28.3-31.21(chr4:134054911-142601496)x1	copy number loss	not provided [RCV000847693]	Chr4:134054911..142601496 [GRCh37] Chr4:4q28.3-31.21	uncertain significance
GRCh37/hg19 4q28.3(chr4:133993419-134954024)x3	copy number gain	not provided [RCV000847165]	Chr4:133993419..134954024 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4q28.1-35.1(chr4:124873497-185278662)x3	copy number gain	not provided [RCV000849686]	Chr4:124873497..185278662 [GRCh37] Chr4:4q28.1-35.1	pathogenic
NM_032961.3(PCDH10):c.768T>C (p.Thr256=)	single nucleotide variant	not provided [RCV000975408]	Chr4:133150908 [GRCh38] Chr4:134072063 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.1283C>T (p.Ser428Phe)	single nucleotide variant	not provided [RCV000905082]	Chr4:133151423 [GRCh38] Chr4:134072578 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.1548T>G (p.Val516=)	single nucleotide variant	not provided [RCV000887982]	Chr4:133151688 [GRCh38] Chr4:134072843 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.2931C>G (p.Gly977=)	single nucleotide variant	not provided [RCV000886063]	Chr4:133163110 [GRCh38] Chr4:134084265 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.1377C>T (p.Asn459=)	single nucleotide variant	not provided [RCV000913810]	Chr4:133151517 [GRCh38] Chr4:134072672 [GRCh37] Chr4:4q28.3	likely benign
NM_032961.3(PCDH10):c.1249A>G (p.Thr417Ala)	single nucleotide variant	not specified [RCV004307483]	Chr4:133151389 [GRCh38] Chr4:134072544 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4q28.3-32.3(chr4:131303317-168722402)x3	copy number gain	not provided [RCV001537926]	Chr4:131303317..168722402 [GRCh37] Chr4:4q28.3-32.3	pathogenic
GRCh37/hg19 4q28.3(chr4:133874103-138426933)x1	copy number loss	not provided [RCV001259315]	Chr4:133874103..138426933 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4q26-28.3(chr4:114872547-138005267)x1	copy number loss	not provided [RCV001795851]	Chr4:114872547..138005267 [GRCh37] Chr4:4q26-28.3	pathogenic
GRCh37/hg19 4q12-31.21(chr4:52866944-143582507)x3	copy number gain	not provided [RCV001827738]	Chr4:52866944..143582507 [GRCh37] Chr4:4q12-31.21	pathogenic
GRCh37/hg19 4q24-31.21(chr4:104715235-145252595)	copy number gain	not specified [RCV002053446]	Chr4:104715235..145252595 [GRCh37] Chr4:4q24-31.21	pathogenic
NM_032961.3(PCDH10):c.677C>T (p.Pro226Leu)	single nucleotide variant	not specified [RCV004327585]	Chr4:133150817 [GRCh38] Chr4:134071972 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1438G>A (p.Ala480Thr)	single nucleotide variant	not specified [RCV004142742]	Chr4:133151578 [GRCh38] Chr4:134072733 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2381A>G (p.Asn794Ser)	single nucleotide variant	not specified [RCV004136166]	Chr4:133152521 [GRCh38] Chr4:134073676 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.911C>T (p.Ser304Leu)	single nucleotide variant	not specified [RCV004120365]	Chr4:133151051 [GRCh38] Chr4:134072206 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2837C>G (p.Ala946Gly)	single nucleotide variant	not specified [RCV004176525]	Chr4:133163016 [GRCh38] Chr4:134084171 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1259C>T (p.Pro420Leu)	single nucleotide variant	not specified [RCV004227195]	Chr4:133151399 [GRCh38] Chr4:134072554 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1457G>A (p.Ser486Asn)	single nucleotide variant	not specified [RCV004132238]	Chr4:133151597 [GRCh38] Chr4:134072752 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2232G>T (p.Lys744Asn)	single nucleotide variant	not specified [RCV004085663]	Chr4:133152372 [GRCh38] Chr4:134073527 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2104C>G (p.Pro702Ala)	single nucleotide variant	not specified [RCV004155956]	Chr4:133152244 [GRCh38] Chr4:134073399 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.845A>G (p.Asn282Ser)	single nucleotide variant	not specified [RCV004230604]	Chr4:133150985 [GRCh38] Chr4:134072140 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1396C>T (p.Pro466Ser)	single nucleotide variant	not specified [RCV004201004]	Chr4:133151536 [GRCh38] Chr4:134072691 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2090G>A (p.Gly697Glu)	single nucleotide variant	not specified [RCV004157758]	Chr4:133152230 [GRCh38] Chr4:134073385 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1442A>T (p.Tyr481Phe)	single nucleotide variant	not specified [RCV004223415]	Chr4:133151582 [GRCh38] Chr4:134072737 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.34A>T (p.Met12Leu)	single nucleotide variant	not specified [RCV004101490]	Chr4:133150174 [GRCh38] Chr4:134071329 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2195C>T (p.Ala732Val)	single nucleotide variant	not specified [RCV004177368]	Chr4:133152335 [GRCh38] Chr4:134073490 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2272C>T (p.Leu758Phe)	single nucleotide variant	not specified [RCV004084282]	Chr4:133152412 [GRCh38] Chr4:134073567 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1469G>T (p.Arg490Leu)	single nucleotide variant	not specified [RCV004223172]	Chr4:133151609 [GRCh38] Chr4:134072764 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2006C>T (p.Ser669Phe)	single nucleotide variant	not specified [RCV004253274]	Chr4:133152146 [GRCh38] Chr4:134073301 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2539G>T (p.Asp847Tyr)	single nucleotide variant	not specified [RCV004287380]	Chr4:133152679 [GRCh38] Chr4:134073834 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1117C>G (p.Pro373Ala)	single nucleotide variant	not specified [RCV004328744]	Chr4:133151257 [GRCh38] Chr4:134072412 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.61C>T (p.His21Tyr)	single nucleotide variant	not specified [RCV004352605]	Chr4:133150201 [GRCh38] Chr4:134071356 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1831G>A (p.Gly611Ser)	single nucleotide variant	not specified [RCV004351649]	Chr4:133151971 [GRCh38] Chr4:134073126 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1727C>A (p.Ala576Glu)	single nucleotide variant	not specified [RCV004353137]	Chr4:133151867 [GRCh38] Chr4:134073022 [GRCh37] Chr4:4q28.3	uncertain significance
GRCh37/hg19 4q26-32.3(chr4:117518683-168174703)x3	copy number gain	not provided [RCV003484198]	Chr4:117518683..168174703 [GRCh37] Chr4:4q26-32.3	pathogenic
GRCh37/hg19 4q27-35.2(chr4:123399154-190957473)x3	copy number gain	not specified [RCV003986533]	Chr4:123399154..190957473 [GRCh37] Chr4:4q27-35.2	pathogenic
GRCh37/hg19 4q24-35.2(chr4:101203509-190957473)x3	copy number gain	not specified [RCV003986496]	Chr4:101203509..190957473 [GRCh37] Chr4:4q24-35.2	pathogenic
GRCh37/hg19 4p12-q35.2(chr4:45455621-191003541)x3	copy number gain	not provided [RCV003885507]	Chr4:45455621..191003541 [GRCh37] Chr4:4p12-q35.2	pathogenic
NM_032961.3(PCDH10):c.751G>C (p.Asp251His)	single nucleotide variant	not specified [RCV004505001]	Chr4:133150891 [GRCh38] Chr4:134072046 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2536A>C (p.Thr846Pro)	single nucleotide variant	not specified [RCV004504995]	Chr4:133152676 [GRCh38] Chr4:134073831 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1969G>A (p.Val657Met)	single nucleotide variant	not specified [RCV004504991]	Chr4:133152109 [GRCh38] Chr4:134073264 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1872C>G (p.Asn624Lys)	single nucleotide variant	not specified [RCV004504990]	Chr4:133152012 [GRCh38] Chr4:134073167 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1790G>T (p.Gly597Val)	single nucleotide variant	not specified [RCV004504989]	Chr4:133151930 [GRCh38] Chr4:134073085 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1598A>G (p.Tyr533Cys)	single nucleotide variant	not specified [RCV004504987]	Chr4:133151738 [GRCh38] Chr4:134072893 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1502C>T (p.Ser501Phe)	single nucleotide variant	not specified [RCV004504986]	Chr4:133151642 [GRCh38] Chr4:134072797 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1306C>T (p.Arg436Trp)	single nucleotide variant	not specified [RCV004504985]	Chr4:133151446 [GRCh38] Chr4:134072601 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.625G>A (p.Gly209Arg)	single nucleotide variant	not specified [RCV004504999]	Chr4:133150765 [GRCh38] Chr4:134071920 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.3074C>T (p.Thr1025Met)	single nucleotide variant	not specified [RCV004504997]	Chr4:133163253 [GRCh38] Chr4:134084408 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1300G>C (p.Val434Leu)	single nucleotide variant	not specified [RCV004504983]	Chr4:133151440 [GRCh38] Chr4:134072595 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2645G>A (p.Arg882Gln)	single nucleotide variant	not specified [RCV004504996]	Chr4:133154320 [GRCh38] Chr4:134075475 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2451G>T (p.Gln817His)	single nucleotide variant	not specified [RCV004504994]	Chr4:133152591 [GRCh38] Chr4:134073746 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2395C>G (p.Pro799Ala)	single nucleotide variant	not specified [RCV004504993]	Chr4:133152535 [GRCh38] Chr4:134073690 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1063G>A (p.Ala355Thr)	single nucleotide variant	not specified [RCV004504981]	Chr4:133151203 [GRCh38] Chr4:134072358 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.107A>G (p.Asn36Ser)	single nucleotide variant	not specified [RCV004504982]	Chr4:133150247 [GRCh38] Chr4:134071402 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.677C>G (p.Pro226Arg)	single nucleotide variant	not specified [RCV004505000]	Chr4:133150817 [GRCh38] Chr4:134071972 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2156T>A (p.Ile719Asn)	single nucleotide variant	not specified [RCV004504992]	Chr4:133152296 [GRCh38] Chr4:134073451 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1675A>G (p.Thr559Ala)	single nucleotide variant	not specified [RCV004504988]	Chr4:133151815 [GRCh38] Chr4:134072970 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1340A>G (p.Lys447Arg)	single nucleotide variant	not specified [RCV004664273]	Chr4:133151480 [GRCh38] Chr4:134072635 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.637G>A (p.Gly213Arg)	single nucleotide variant	not specified [RCV004664274]	Chr4:133150777 [GRCh38] Chr4:134071932 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2550C>G (p.His850Gln)	single nucleotide variant	not specified [RCV004664269]	Chr4:133152690 [GRCh38] Chr4:134073845 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2624C>T (p.Ser875Phe)	single nucleotide variant	not specified [RCV004664270]	Chr4:133152764 [GRCh38] Chr4:134073919 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.3057T>A (p.Asp1019Glu)	single nucleotide variant	not specified [RCV004664271]	Chr4:133163236 [GRCh38] Chr4:134084391 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.288G>C (p.Glu96Asp)	single nucleotide variant	not specified [RCV004664275]	Chr4:133150428 [GRCh38] Chr4:134071583 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2681G>A (p.Arg894Gln)	single nucleotide variant	not specified [RCV004653043]	Chr4:133154356 [GRCh38] Chr4:134075511 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.469C>A (p.Arg157Ser)	single nucleotide variant	not specified [RCV004653044]	Chr4:133150609 [GRCh38] Chr4:134071764 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.146C>T (p.Ser49Leu)	single nucleotide variant	not specified [RCV004653045]	Chr4:133150286 [GRCh38] Chr4:134071441 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2399C>G (p.Ala800Gly)	single nucleotide variant	not specified [RCV004664268]	Chr4:133152539 [GRCh38] Chr4:134073694 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1891A>G (p.Met631Val)	single nucleotide variant	not specified [RCV004836473]	Chr4:133152031 [GRCh38] Chr4:134073186 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2257G>A (p.Ala753Thr)	single nucleotide variant	not specified [RCV004836476]	Chr4:133152397 [GRCh38] Chr4:134073552 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.229G>A (p.Glu77Lys)	single nucleotide variant	not specified [RCV004836478]	Chr4:133150369 [GRCh38] Chr4:134071524 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2113T>C (p.Ser705Pro)	single nucleotide variant	not specified [RCV004836477]	Chr4:133152253 [GRCh38] Chr4:134073408 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.2989G>A (p.Glu997Lys)	single nucleotide variant	not specified [RCV004836479]	Chr4:133163168 [GRCh38] Chr4:134084323 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1928G>C (p.Arg643Pro)	single nucleotide variant	not specified [RCV004836480]	Chr4:133152068 [GRCh38] Chr4:134073223 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1279G>A (p.Asp427Asn)	single nucleotide variant	not specified [RCV004830305]	Chr4:133151419 [GRCh38] Chr4:134072574 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1750A>T (p.Thr584Ser)	single nucleotide variant	not specified [RCV004830306]	Chr4:133151890 [GRCh38] Chr4:134073045 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.28C>T (p.Leu10Phe)	single nucleotide variant	not specified [RCV004836474]	Chr4:133150168 [GRCh38] Chr4:134071323 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1544A>T (p.Tyr515Phe)	single nucleotide variant	not specified [RCV004836481]	Chr4:133151684 [GRCh38] Chr4:134072839 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.488C>T (p.Pro163Leu)	single nucleotide variant	not specified [RCV004836471]	Chr4:133150628 [GRCh38] Chr4:134071783 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.683A>C (p.Gln228Pro)	single nucleotide variant	not specified [RCV004836472]	Chr4:133150823 [GRCh38] Chr4:134071978 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1614C>G (p.Asp538Glu)	single nucleotide variant	not specified [RCV004836475]	Chr4:133151754 [GRCh38] Chr4:134072909 [GRCh37] Chr4:4q28.3	uncertain significance
NM_032961.3(PCDH10):c.1604A>C (p.Gln535Pro)	single nucleotide variant	not specified [RCV004836482]	Chr4:133151744 [GRCh38] Chr4:134072899 [GRCh37] Chr4:4q28.3	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	1143
Count of miRNA genes:	617
Interacting mature miRNAs:	693
Transcripts:	ENST00000264360, ENST00000511112
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597507600	GWAS1603674_H	level of Phosphatidylcholine (O-16:0_16:1) in blood serum QTL GWAS1603674 (human)		3e-08	level of Phosphatidylcholine (O-16:0_16:1) in blood serum		4	133202073	133202074	Human

PCDH10_3290.2

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	134,073,739 - 134,074,597	UniSTS	GRCh37
Build 36	4	134,293,189 - 134,294,047	RGD	NCBI36
Celera	4	131,412,749 - 131,413,607	RGD
HuRef	4	129,802,496 - 129,803,354	UniSTS

L29660

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	134,070,805 - 134,070,929	UniSTS	GRCh37
Build 36	4	134,290,255 - 134,290,379	RGD	NCBI36
Celera	4	131,409,815 - 131,409,939	RGD
Cytogenetic Map	4	q28.3	UniSTS
HuRef	4	129,799,562 - 129,799,686	UniSTS

SHGC-24774

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	4	134,112,578 - 134,112,702	UniSTS	GRCh37
Build 36	4	134,332,028 - 134,332,152	RGD	NCBI36
Celera	4	131,451,590 - 131,451,714	RGD
Cytogenetic Map	4	q28.3	UniSTS
HuRef	4	129,841,330 - 129,841,454	UniSTS
GeneMap99-GB4 RH Map	4	589.39	UniSTS
Whitehead-RH Map	4	646.2	UniSTS
GeneMap99-G3 RH Map	4	8670.0	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1181	2270	2723	2192	4915	1478	2018	2	394	994	233	2213	5871	5451	44	3722	802	1649	1517	167


RefSeq Transcripts	NM_020815	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_032961	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011532150	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054350597	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB037821	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC105383	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC136785	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AI479918	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK024636	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK314377	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL157470	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AW007480	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AY013874	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC039411	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC042378	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC111560	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CB052787	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471056	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068274	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CX760781	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DA318338	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KJ534913	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KJ534914	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	Z60272	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000264360 ⟹ ENSP00000264360

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	133,149,294 - 133,194,700 (+)	Ensembl

Ensembl Acc Id:

ENST00000511112

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	133,154,893 - 133,208,606 (+)	Ensembl

Ensembl Acc Id:

ENST00000618019 ⟹ ENSP00000480512

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	4	133,149,315 - 133,153,888 (+)	Ensembl

RefSeq Acc Id:

NM_020815 ⟹ NP_065866

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	133,149,294 - 133,153,888 (+)	NCBI
GRCh37	4	134,070,470 - 134,112,732 (+)	ENTREZGENE
Build 36	4	134,289,920 - 134,293,854 (+)	NCBI Archive
HuRef	4	129,799,227 - 129,841,484 (+)	ENTREZGENE
CHM1_1	4	134,046,920 - 134,051,505 (+)	NCBI
T2T-CHM13v2.0	4	136,472,535 - 136,477,129 (+)	NCBI

Sequence:

show sequence

AGAAACTGCCAGCCCAGACCACAGGCTCAGAGGCTGAAGCAGGAGGAAGGAAGGACTGGAAGGAAAAAGAGACAGGTTAGAGGGAAAGAGGCTTGGGAAGAAAACAGCAGAAAAGAAACTGCTCATTA
CACTTACAGAGAGGCAAGTAACGGTGGAGATGAGGACAGAGGGAACCAAGACTCTGAAAGACAAAAAATACAAATAGAGCGAAAGAGGAAAAAAATGTCAAGAAGAACATCCATCCGGAGAAATGAAG
AGAATGAAAGTTTTAAGCTGCAGAGCCGTTCTGTGCTTTTCCGGCACAAAATTATATCGCTGATTTTAAGCCCTTTTGCATTTGCCAGCCGTTGACATTAAGAGGCATGTTTAACGGTGCCAACAGCA
TCTCCTTTTCCTTCTCCTCTTCCTCTTCTTCTTCTTCCTCCTCCTCCTCCTCTTTTTCCTCCTCCTCGTTCTCCTCCCATCAGCAAGAAGACAAACCGAGGACAGTCTTGAAATATCGAAATTTCCTC
TTTGGGATTTGCCAGCGCCAAGACTGTCGGAATAAAGGACGCTGACTATTGTATTATTGTTATTTTATTAATTAGTCAGTGGAAAGATTACAGATGAGGAAAGGGGACGCCTGTCACCCTTCCTGTGC
TAAGATTTAAAAAAAAATGAGGCTGGATTGCGGGAAGCTCTAAAATGAAGCAAAAGGAGTAAGATTTTTAAAGACAGAAAGCCACAGGAGCCCCCACGTAGCGCACTTTTATTTGTATTTTTTCAGAT
TTTTTTTTGTTTCGTGGTGGTGGGGGAGGTGATTGGGTGGCTGACTGGCTGCGGGAAGCTACTTCCTTTCCTTTTGGAGATGATTGTGCTATTATTGTTTGCCTTGCTCTGGATGGTGGAAGGAGTCT
TTTCCCAGCTTCACTACACGGTACAGGAGGAGCAGGAACATGGCACTTTCGTGGGGAATATCGCTGAAGATCTGGGTCTGGACATTACAAAACTTTCGGCTCGCGGGTTTCAGACGGTGCCCAACTCA
AGGACCCCTTACTTAGACCTCAACCTGGAGACAGGGGTGCTGTACGTGAACGAGAAAATAGACCGCGAACAAATCTGCAAACAGAGCCCCTCCTGTGTCCTGCACCTGGAGGTCTTTCTGGAGAACCC
CCTGGAGCTGTTCCAGGTGGAGATCGAGGTGCTGGACATTAATGACAACCCCCCCTCTTTCCCGGAGCCAGACCTGACGGTGGAAATCTCTGAGAGCGCCACGCCAGGCACTCGCTTCCCCTTGGAGA
GCGCATTCGACCCAGACGTGGGCACCAACTCCTTGCGCGACTACGAGATCACCCCCAACAGCTACTTCTCCCTGGACGTGCAGACCCAGGGGGATGGCAACCGATTCGCTGAGCTGGTGCTGGAGAAG
CCACTGGACCGAGAGCAGCAAGCGGTGCACCGCTACGTGCTGACCGCGGTGGACGGAGGAGGTGGGGGAGGAGTAGGAGAAGGAGGGGGAGGTGGCGGGGGAGCAGGCCTGCCCCCCCAGCAGCAGCG
CACCGGCACGGCCCTACTCACCATCCGAGTGCTGGACTCCAATGACAATGTGCCCGCTTTCGACCAACCCGTCTACACTGTGTCCCTACCAGAGAACTCTCCCCCAGGCACTCTCGTGATCCAGCTCA
ACGCCACCGACCCGGACGAGGGCCAGAACGGTGAGGTCGTGTACTCCTTCAGCAGCCACATTTCGCCCCGGGCGCGGGAGCTTTTCGGACTCTCGCCGCGCACTGGCAGACTGGAGGTAAGCGGCGAG
TTGGACTATGAAGAGAGCCCAGTGTACCAAGTGTACGTGCAAGCCAAGGACCTGGGCCCCAACGCCGTGCCTGCGCACTGCAAGGTGCTAGTGCGAGTACTGGATGCTAATGACAACGCGCCAGAGAT
CAGCTTCAGCACCGTGAAGGAAGCGGTGAGTGAGGGCGCGGCGCCCGGCACTGTGGTGGCCCTTTTCAGCGTGACTGACCGCGACTCAGAGGAGAATGGGCAGGTGCAGTGCGAGCTACTGGGAGACG
TGCCTTTCCGCCTCAAGTCTTCCTTTAAGAATTACTACACCATCGTTACCGAAGCCCCCCTGGACCGAGAGGCGGGGGACTCCTACACCCTGACTGTAGTGGCTCGGGACCGGGGCGAGCCTGCGCTC
TCCACCAGTAAGTCGATCCAGGTACAAGTGTCGGATGTGAACGACAACGCGCCGCGTTTCAGCCAGCCGGTCTACGACGTGTATGTGACTGAAAACAACGTGCCTGGCGCCTACATCTACGCGGTGAG
CGCCACCGACCGGGATGAGGGCGCCAACGCCCAGCTTGCCTACTCTATCCTCGAGTGCCAGATCCAGGGCATGAGCGTCTTCACCTACGTTTCTATCAACTCTGAGAACGGCTACTTGTACGCCCTGC
GCTCCTTCGACTATGAGCAGCTGAAGGACTTCAGTTTTCAGGTGGAAGCCCGGGACGCTGGCAGCCCCCAGGCGCTGGCTGGTAACGCCACTGTCAACATCCTCATAGTGGATCAAAATGACAACGCC
CCTGCCATCGTGGCGCCTCTACCAGGGCGCAACGGGACTCCAGCGCGTGAGGTGCTGCCCCGCTCGGCGGAGCCGGGTTACCTGCTCACCCGCGTGGCCGCCGTGGACGCGGACGACGGCGAGAACGC
CCGGCTCACTTACAGCATCGTGCGTGGCAACGAAATGAACCTCTTTCGCATGGACTGGCGCACCGGGGAGCTGCGCACAGCACGCCGAGTCCCGGCCAAGCGCGACCCCCAGCGGCCTTATGAGCTGG
TGATCGAGGTGCGCGACCATGGGCAGCCGCCCCTTTCCTCCACCGCCACCCTGGTGGTTCAGCTGGTGGATGGCGCCGTGGAGCCCCAGGGCGGGGGCGGGAGCGGAGGCGGAGGGTCAGGAGAGCAC
CAGCGCCCCAGTCGCTCTGGCGGCGGGGAAACCTCGCTAGACCTCACCCTCATCCTCATCATCGCGTTGGGCTCGGTGTCCTTCATCTTCCTGCTGGCCATGATCGTGCTGGCCGTGCGTTGCCAAAA
AGAGAAGAAGCTCAACATCTATACTTGTCTGGCCAGCGATTGCTGCCTCTGCTGCTGCTGCTGCGGTGGCGGAGGTTCGACCTGCTGTGGCCGCCAAGCCCGGGCGCGCAAGAAGAAACTCAGCAAGT
CAGACATCATGCTGGTGCAGAGCTCCAATGTACCCAGTAACCCGGCCCAGGTGCCGATAGAGGAGTCCGGGGGCTTTGGCTCCCACCACCACAACCAGAATTACTGCTATCAGGTATGCCTGACCCCT
GAGTCCGCCAAGACCGACCTGATGTTTCTTAAGCCCTGCAGCCCTTCGCGGAGTACGGACACTGAGCACAACCCCTGCGGGGCCATCGTCACCGGTTACACCGACCAGCAGCCTGATATCATCTCCAA
CGGAAGCATTTTGTCCAACGAGGTAAGGCTGAAGCGAAAGGACCACCATCTCTCATCTCCTCCATCAGAAAGCCTCCTCTAGCCCGGCCCTTGTATCTCTGGTGCACTGTATCTATTTTTAGGATATT
AGCTTATGTGTATCGTTGTGGGAGCAGAGATGGGCGGTCACCTTCTCCCACTCCTTCGTGTGTAACCTAACTTTCGCGTTGTTCCACCCTTTCACATTTATTTTCATTCCGTCCCCTTGGTACTTTGC
CACCTTGGAGCTCCCTCCTTTGCTCTTCCATCCTGTCAGTCCTTTCCCTTCTCAGTAACCTGGGCATGAAGGGAAACTGCGTGAAGGGAGAGGGAAATGTGGAGGAGGGACTTACTTTCTAGCACTGG
CAAAGGTCTTTTTTCTTTGCGTCTGTCCCAGGCATTAATAAAGTTGGCTCTATTTTGCTTTGTTTAACGATGCTTTTAGTCGCGTGTACAAGTAAGCTATAGATTGTTTAACTTTACACAGTTGTCTA
ACCTCGAATTCATGTTTTAGTGAACAAGTTACCAGATCCTTCTCCTCTGAACTCGGGTTGCAAAAAAAGCCTTCAGTTCGGCTCTGGACAGCATTTACAGACGCTCTTGAAGCCGAGCGCCCACACAG
TGTGAATTTGAATGAAGCTGCGTTGGCACAAACCCCTGTTAAGAGTAAACTAACGAAAGGCTTAAACAATTGTTGTCTTAAATATATCTTTTTAGCTAATAATCACCTTCTTGCCACTGTTTTGGATA
AATCACGCTGTTGGCTTTCTTCATAAAAGAATTTGGCTTGTCAATTCTGACTTCTTTTTAAAAGGATGGAGAAGTGACAAAGTCGGAGGGTGGGGGTTGGGGGGAGAACAAAGTTGGTTTATGTGAAA
GAAAGCTTGGACCGGAAAGGTGTGTGGGTGGTAGAGGTGGGGAGGCGAATGCAGAGGGCCTTTGGAGGGGAAAAGAATGGGGGTGGTGGGGGGCGGGCAGGATTATGAACTCCTTTCCTGGCAGGTTA
TTTTATTTGAGTCTTAGATATTATTAATTGACTTTCATGAATATTTGTACAGCTCATTTGTATCTTAAGCACATTTTGAAAATAAACAACAACATAATTCCATGAAATATCCAAA

hide sequence

RefSeq Acc Id:

NM_032961 ⟹ NP_116586

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	133,149,294 - 133,194,700 (+)	NCBI
GRCh37	4	134,070,470 - 134,112,732 (+)	ENTREZGENE
Build 36	4	134,289,920 - 134,332,182 (+)	NCBI Archive
HuRef	4	129,799,227 - 129,841,484 (+)	ENTREZGENE
CHM1_1	4	134,046,920 - 134,092,233 (+)	NCBI
T2T-CHM13v2.0	4	136,472,535 - 136,517,933 (+)	NCBI

Sequence:

show sequence

AGAAACTGCCAGCCCAGACCACAGGCTCAGAGGCTGAAGCAGGAGGAAGGAAGGACTGGAAGGAAAAAGAGACAGGTTAGAGGGAAAGAGGCTTGGGAAGAAAACAGCAGAAAAGAAACTGCTCATTA
CACTTACAGAGAGGCAAGTAACGGTGGAGATGAGGACAGAGGGAACCAAGACTCTGAAAGACAAAAAATACAAATAGAGCGAAAGAGGAAAAAAATGTCAAGAAGAACATCCATCCGGAGAAATGAAG
AGAATGAAAGTTTTAAGCTGCAGAGCCGTTCTGTGCTTTTCCGGCACAAAATTATATCGCTGATTTTAAGCCCTTTTGCATTTGCCAGCCGTTGACATTAAGAGGCATGTTTAACGGTGCCAACAGCA
TCTCCTTTTCCTTCTCCTCTTCCTCTTCTTCTTCTTCCTCCTCCTCCTCCTCTTTTTCCTCCTCCTCGTTCTCCTCCCATCAGCAAGAAGACAAACCGAGGACAGTCTTGAAATATCGAAATTTCCTC
TTTGGGATTTGCCAGCGCCAAGACTGTCGGAATAAAGGACGCTGACTATTGTATTATTGTTATTTTATTAATTAGTCAGTGGAAAGATTACAGATGAGGAAAGGGGACGCCTGTCACCCTTCCTGTGC
TAAGATTTAAAAAAAAATGAGGCTGGATTGCGGGAAGCTCTAAAATGAAGCAAAAGGAGTAAGATTTTTAAAGACAGAAAGCCACAGGAGCCCCCACGTAGCGCACTTTTATTTGTATTTTTTCAGAT
TTTTTTTTGTTTCGTGGTGGTGGGGGAGGTGATTGGGTGGCTGACTGGCTGCGGGAAGCTACTTCCTTTCCTTTTGGAGATGATTGTGCTATTATTGTTTGCCTTGCTCTGGATGGTGGAAGGAGTCT
TTTCCCAGCTTCACTACACGGTACAGGAGGAGCAGGAACATGGCACTTTCGTGGGGAATATCGCTGAAGATCTGGGTCTGGACATTACAAAACTTTCGGCTCGCGGGTTTCAGACGGTGCCCAACTCA
AGGACCCCTTACTTAGACCTCAACCTGGAGACAGGGGTGCTGTACGTGAACGAGAAAATAGACCGCGAACAAATCTGCAAACAGAGCCCCTCCTGTGTCCTGCACCTGGAGGTCTTTCTGGAGAACCC
CCTGGAGCTGTTCCAGGTGGAGATCGAGGTGCTGGACATTAATGACAACCCCCCCTCTTTCCCGGAGCCAGACCTGACGGTGGAAATCTCTGAGAGCGCCACGCCAGGCACTCGCTTCCCCTTGGAGA
GCGCATTCGACCCAGACGTGGGCACCAACTCCTTGCGCGACTACGAGATCACCCCCAACAGCTACTTCTCCCTGGACGTGCAGACCCAGGGGGATGGCAACCGATTCGCTGAGCTGGTGCTGGAGAAG
CCACTGGACCGAGAGCAGCAAGCGGTGCACCGCTACGTGCTGACCGCGGTGGACGGAGGAGGTGGGGGAGGAGTAGGAGAAGGAGGGGGAGGTGGCGGGGGAGCAGGCCTGCCCCCCCAGCAGCAGCG
CACCGGCACGGCCCTACTCACCATCCGAGTGCTGGACTCCAATGACAATGTGCCCGCTTTCGACCAACCCGTCTACACTGTGTCCCTACCAGAGAACTCTCCCCCAGGCACTCTCGTGATCCAGCTCA
ACGCCACCGACCCGGACGAGGGCCAGAACGGTGAGGTCGTGTACTCCTTCAGCAGCCACATTTCGCCCCGGGCGCGGGAGCTTTTCGGACTCTCGCCGCGCACTGGCAGACTGGAGGTAAGCGGCGAG
TTGGACTATGAAGAGAGCCCAGTGTACCAAGTGTACGTGCAAGCCAAGGACCTGGGCCCCAACGCCGTGCCTGCGCACTGCAAGGTGCTAGTGCGAGTACTGGATGCTAATGACAACGCGCCAGAGAT
CAGCTTCAGCACCGTGAAGGAAGCGGTGAGTGAGGGCGCGGCGCCCGGCACTGTGGTGGCCCTTTTCAGCGTGACTGACCGCGACTCAGAGGAGAATGGGCAGGTGCAGTGCGAGCTACTGGGAGACG
TGCCTTTCCGCCTCAAGTCTTCCTTTAAGAATTACTACACCATCGTTACCGAAGCCCCCCTGGACCGAGAGGCGGGGGACTCCTACACCCTGACTGTAGTGGCTCGGGACCGGGGCGAGCCTGCGCTC
TCCACCAGTAAGTCGATCCAGGTACAAGTGTCGGATGTGAACGACAACGCGCCGCGTTTCAGCCAGCCGGTCTACGACGTGTATGTGACTGAAAACAACGTGCCTGGCGCCTACATCTACGCGGTGAG
CGCCACCGACCGGGATGAGGGCGCCAACGCCCAGCTTGCCTACTCTATCCTCGAGTGCCAGATCCAGGGCATGAGCGTCTTCACCTACGTTTCTATCAACTCTGAGAACGGCTACTTGTACGCCCTGC
GCTCCTTCGACTATGAGCAGCTGAAGGACTTCAGTTTTCAGGTGGAAGCCCGGGACGCTGGCAGCCCCCAGGCGCTGGCTGGTAACGCCACTGTCAACATCCTCATAGTGGATCAAAATGACAACGCC
CCTGCCATCGTGGCGCCTCTACCAGGGCGCAACGGGACTCCAGCGCGTGAGGTGCTGCCCCGCTCGGCGGAGCCGGGTTACCTGCTCACCCGCGTGGCCGCCGTGGACGCGGACGACGGCGAGAACGC
CCGGCTCACTTACAGCATCGTGCGTGGCAACGAAATGAACCTCTTTCGCATGGACTGGCGCACCGGGGAGCTGCGCACAGCACGCCGAGTCCCGGCCAAGCGCGACCCCCAGCGGCCTTATGAGCTGG
TGATCGAGGTGCGCGACCATGGGCAGCCGCCCCTTTCCTCCACCGCCACCCTGGTGGTTCAGCTGGTGGATGGCGCCGTGGAGCCCCAGGGCGGGGGCGGGAGCGGAGGCGGAGGGTCAGGAGAGCAC
CAGCGCCCCAGTCGCTCTGGCGGCGGGGAAACCTCGCTAGACCTCACCCTCATCCTCATCATCGCGTTGGGCTCGGTGTCCTTCATCTTCCTGCTGGCCATGATCGTGCTGGCCGTGCGTTGCCAAAA
AGAGAAGAAGCTCAACATCTATACTTGTCTGGCCAGCGATTGCTGCCTCTGCTGCTGCTGCTGCGGTGGCGGAGGTTCGACCTGCTGTGGCCGCCAAGCCCGGGCGCGCAAGAAGAAACTCAGCAAGT
CAGACATCATGCTGGTGCAGAGCTCCAATGTACCCAGTAACCCGGCCCAGGTGCCGATAGAGGAGTCCGGGGGCTTTGGCTCCCACCACCACAACCAGAATTACTGCTATCAGGTATGCCTGACCCCT
GAGTCCGCCAAGACCGACCTGATGTTTCTTAAGCCCTGCAGCCCTTCGCGGAGTACGGACACTGAGCACAACCCCTGCGGGGCCATCGTCACCGGTTACACCGACCAGCAGCCTGATATCATCTCCAA
CGGAAGCATTTTGTCCAACGAGACTAAACACCAGCGAGCAGAGCTCAGCTATCTAGTTGACAGACCTCGCCGAGTTAACAGTTCTGCATTCCAGGAAGCCGACATAGTAAGCTCTAAGGACAGTGGTC
ATGGAGACAGTGAACAGGGAGATAGTGATCATGATGCCACCAACCGTGCCCAGTCAGCTGGTATGGATCTCTTCTCCAATTGCACTGAGGAATGTAAAGCTCTGGGCCACTCAGATCGGTGCTGGATG
CCTTCTTTTGTCCCTTCTGATGGACGCCAGGCTGCTGATTATCGCAGCAATCTGCATGTTCCTGGCATGGACTCTGTTCCAGACACTGAGGTGTTTGAAACTCCAGAAGCCCAGCCTGGGGCAGAGCG
GTCCTTTTCCACCTTTGGCAAAGAGAAGGCCCTTCACAGCACTCTGGAGAGGAAGGAGCTGGATGGACTGCTGACTAATACGCGAGCGCCTTACAAACCACCATATTTGACACGGAAAAGGATATGCT
AGTCAATTCTACAGGACTTACCTGAAGCAGCATGATTTGCACAAAGTCGACCAACAAAAGCATCAACTTTTCAACTTCATTATCTTGGCCATCCAGTTAGTCATGTGTAACTGAGTATTAGATTTCGG
ATGGAGTCATCATGGCCAATTATAGGACCTAATTGCTCTCAGCAGGCCTGAGAAATGAGTTGAAATGTGCAGAACTGTAGAAACTTTAGAGGCAACAGATTTTGCCTCCCCGATCAGTGTGTGCCTGT
TTACAGCACTATCTATCTTTCTCTCTCCAAATGTCACTGAGCCCTTTAGATGTTTATATTCACCACGAGAAGCCAGTCATAAAGATAAAGGAAATTTGTGCATTATAAATGCAATATCACTGTTTTAA
ACTTGACTGTTTTATATTATTTTTGTGTGATCAAGTGTTCCGCAAGCTATTCCAACTTTACAAGAGAAATTGTGATTATGTTCTTTTCACCTGTGGGTTATAAAAAATGTTGTATTCTGAAGACCCAC
AAAATATCAAAGACATTCTGTAGTTTATACACCGTGTTGCAAAGTGTTTACTGTACTATTTCAAAGCTTCTAAATAAATATAAAATATATATATTATATTATATAATTTTCCTAAAATGTGGTACAAC
TCAGTTGGTTTTTAAATGGATGCATACAGTCCACATCATACAATAAAATAAAAGGTAATTCAGGGTCCCAAAGACAAACTTACTAAGAAAAAATCATTAATAGTTTTCTCCCAATTTCCATATCTTAC
TCAACCGTGTTTTTCCTTGTTTAAAAGAAAATGATGCTCTAAGCTACAAAATTTTGTCAAAAACTCATATTGAATTTTCAATGCCAAAGATGTAGCTATTGATGTTATCAGACAGAGCACTGACTATG
TACTATCAAACTATCTAACAATCTGCATAAGTCTGATTCTATTTCTATGACTTTGAATTTAGAATCACTTAAAGCTTTTATAAAGAATCGATAAATTCACCTGTATTTGTTGTTAGAAAAAAACTGGG
TGTCTGTACATTTTGTGGTGTAAAATATGTAATTGAAGATTACTATTTTAAGAAGTCATCAGTCATATCACTCACACAGAATTTTATTTTACATAGTTTTGTGACTTAATTACACATGAATATAAAAT
CTATAATTCTATATGAATATATAGAGATATAGAAACATCTGAACTGGTAAAGAATAACTATAAAATATGAAAGCTCTAAATTTAAAATAAATTTAGAGATAGAATCATGGTACATTATTGTTTCAGTA
TTCCATGTGAAAATTTTATAGCTTAAATGTAGTCAGTGTTTGATTAATGAAAAAATTCTTCATGAGTCAGCCTTCAAAAGTTAAGCTTGCCTTTTACTTTTATGTCAACAATATTAATTATTAAATTT
AGTAAGACGCACTTTCCTTTCTTTTATATATTTTTTCTACTGTTGTGTATGCCTTGTTAGAACACATTCGAGAGAGGAAAAAAATCAGAGAATATAAGATAATCTTTCAAGCAAAAAACAGAATTGTC
ACAGCTCCCCTCGCCCTCTAAACTATGATATCAAAACATCATATCAAAGCTTCAACATTATATCAAAATGTTTGCCCAGTTCAAATTAGAAACCTGTTTTGAAATACTTTCCTTAATTTTTAACTGAT
CTTATATTCAATGACAGTTTGAGCTGCACTGTGTTATTAAAGAATAGACTAAAACTTAACATTTGACAAATGTTCTTCATCAAATTTTATGTAACTTAAGTGGAAATTTTTCCCTAGATTTAACTTTA
AAATACATATATATACACACACACACACACACACACACACACACACTTAGGTCCTGATATGTACATTTAGAGTGATATATTGGTATCACTCATTTGACTGTTATCAAATTAGATATTAATATATCATA
TTCCAATCAGTTCATATATCAAAATAATGTATGTAATGTTCCAGCCTTTTGAAGTCTCTTTAAACATATATGAAGCTAACAGATCATATGTAATACAAAAAGCACATAAATTCACTAAGTGCAGCAGT
AACATTTTCTTAAACTTTGGCATTACTACATTAATATTTTGAATGATAGACTATTTTAGTAAGGAAATGTTTATACATAATTTAACTGGAAAAAAGTCTGTTTGTTCCAACTCTTTTTTTTAGCAAGA
AAATGATTTTCTTGTTGAGTCACTCTGCTTTAATTAAAATGTTTCACGCATCATTTTGCAATCATGGGTGAATATCCACATCCATCTTCCTTACTGCATGCATTGAAAATAAGATTATACTCACTTCA
TGTATAGTAATTATATTGTCATTTACCTCAAAGACATTTTCTTTAATTATTTAACCTTTTATATCATTGTATATAATCTCCTTTGAACCAACTTTTTTATTATATATTTGTGTATTAGTTATTTTCAT
ATATCCTAGGAACTAGTTATACTAACTTACATTTTAGTTATCATCAATCTACAAAACCAAAACCAGAACTTCTTCCTAATTTGCGGGACAAATAGAATTGTTTAAGGATAAAATGCTACATTATTAGG
TCATTAATCAACTTATCTGTTGCATCCAAAGTAAATTAGAAGTTACAACAGAGTAAGGATATGATTCTTGTAAGTTGGTTAAAATGTTTTCTTCCAATGAGGGGGACTATAAAATGGAAAGTGCAACC
AACAAATAATGAAGGTTTCTAATTAAGCATTTACTAGATTAATATATCAAGGAATTTTAGGATAGGTTTTCTCTTTAATCTGGTCATTCTAATATCCAATCTTACATAATTTTATATACATCAAAGAA
TAATATCCATCGTATTAGACAGTATTTCGTCAATAAATTATTTCAGAAAAAAAAATCATGTCATTTACTCCTTGTTAACATGGTTAGTTTTAGAGCAGTCAAAGTCAAAAAAAATTTCCTGTGGAAAC
AGTGTCTTAATGTTTCAAAGGTATGTCAAAAGACAATTTTTAGAAAATATTTCATCCACATGTAGAATTCTAATTTTTAACGTGTGAACATAGTTTGGTGAAATCATCTTAAATCAAATTTAAATATC
ACATCAGAATTACTTCACAGATATAATAGCGTCAATGATATATGTATCATCTTTTCTTGGCAAATATTAAGGAAATATGTGTATTTTATTTTTTAAAGATATTAAATGCACTGCCTTTATCAAACATT
GCAAATTAAGAACTATAGTAGAATATTTAAATATTTTAATTTCTCATTGTTTTATTTGTTAATTGGATTGTAATTTGCCATCAGATTCTCTGTATTATAGAAGCTATCTTGCTTCTTCAATAAGAGGA
GGAAAAAGAATCTCACAATTCCCAATATAATCTTTAACAACTGTACGTTAATTGTACCATTTTACCTTCTAAACATTATTTACTGGAGCTCAGTTAGTCTTTAAAACAATTACTCAGGCAGAGTGTGG
CAAAAGTTCAGCAAGATCAAGAAAAGTATTTAAGTTATTGACTGATCATAGCACTGTTATTTGTCATTGCATGTGTTTTTCCCCCTCATGTTTCTATGTGTGCTATTGATACCCAAGGAACTCAAAAA
TACTTAAAATATTGGTATACTTGATGATTTTTCTGAAAATCTTATATTTTTCATATTACAAATTCTTGAGTTCTTTATCTTTTTCAAGTCTAATTTTGTAGTGGTAAAGGCTTTGCACTTAACATCCT
TTTGTGTTCCTTTTTAACAAGGAAAAACAGAAAATAATGGAATTCCATATTTTTTACACCATGGAGTAGTAAAATTATTTTATATATTGTTAGTACTTCAACAAACATCCCTCTGCTAAGTCAGACAA
AATCCTTATACAGTAATTTGTGAAACTGTTCAGTAGAGTATTCTTTTCTTCAAATCTTGGCATAGGTTTTAGATTATAGCATTCTGTATGAATGCAGGTAGATGGGTGCCGCCAGAGTATTGCAGGCA
ATAATACGACTAAAATTCTAATACTTTTAGTGTGCATGCGTGTATTTCTAATCACTGTTATTTTTTAAGTATTTGTAAAATTAGAAAAATTGCTTTTATTTCTTGAAAAGTTGTCACATGCTTAGTTT
GAAGTTTTACTCTCCAGATGTTTTTGAGTTGCATAAAAATCTTGCATTCATCATTCAAAAAATACTAAATTTCACATGAGACTCAAAAATTTCTGAATGATGGAACTCAGACTTCCAATACATTCATA
CATGCTAGAGCTGAAAGTAAGCAGGGAATTTCAGCTCTAAACACATTTTTGAGACAGTTATCTGTGAGTGAAAACAGGGTATTATAACAAAAGATGAGTTTCAATCTTAACTACAGTGTTTGTTACTG
TGAATGCTATAATAATACATAAGTAAAATGAGTGTAAATGTAATAAATTATTTTATACTGCTGTATACATATGAAATAAATAAAACTAGGATACATATTATGCCATTTTTCCATGCATGGATCTTCCA
CTGACGCCTGTGGGAGCTTTGAATAAAAATCAGTGGCAAATATGGCTCTAAGTTTAAAAACA

hide sequence

RefSeq Acc Id:

XM_011532150 ⟹ XP_011530452

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	133,149,294 - 133,208,606 (+)	NCBI

Sequence:

show sequence

AGAAACTGCCAGCCCAGACCACAGGCTCAGAGGCTGAAGCAGGAGGAAGGAAGGACTGGAAGGA
AAAAGAGACAGGTTAGAGGGAAAGAGGCTTGGGAAGAAAACAGCAGAAAAGAAACTGCTCATTACACTTACAGAGAGGCAAGTAACGGTGGAGATGAGGACAGAGGGAACCAAGACTCTGAAAGACAA
AAAATACAAATAGAGCGAAAGAGGAAAAAAATGTCAAGAAGAACATCCATCCGGAGAAATGAAGAGAATGAAAGTTTTAAGCTGCAGAGCCGTTCTGTGCTTTTCCGGCACAAAATTATATCGCTGAT
TTTAAGCCCTTTTGCATTTGCCAGCCGTTGACATTAAGAGGCATGTTTAACGGTGCCAACAGCATCTCCTTTTCCTTCTCCTCTTCCTCTTCTTCTTCTTCCTCCTCCTCCTCCTCTTTTTCCTCCTC
CTCGTTCTCCTCCCATCAGCAAGAAGACAAACCGAGGACAGTCTTGAAATATCGAAATTTCCTCTTTGGGATTTGCCAGCGCCAAGACTGTCGGAATAAAGGACGCTGACTATTGTATTATTGTTATT
TTATTAATTAGTCAGTGGAAAGATTACAGATGAGGAAAGGGGACGCCTGTCACCCTTCCTGTGCTAAGATTTAAAAAAAAATGAGGCTGGATTGCGGGAAGCTCTAAAATGAAGCAAAAGGAGTAAGA
TTTTTAAAGACAGAAAGCCACAGGAGCCCCCACGTAGCGCACTTTTATTTGTATTTTTTCAGATTTTTTTTTGTTTCGTGGTGGTGGGGGAGGTGATTGGGTGGCTGACTGGCTGCGGGAAGCTACTT
CCTTTCCTTTTGGAGATGATTGTGCTATTATTGTTTGCCTTGCTCTGGATGGTGGAAGGAGTCTTTTCCCAGCTTCACTACACGGTACAGGAGGAGCAGGAACATGGCACTTTCGTGGGGAATATCGC
TGAAGATCTGGGTCTGGACATTACAAAACTTTCGGCTCGCGGGTTTCAGACGGTGCCCAACTCAAGGACCCCTTACTTAGACCTCAACCTGGAGACAGGGGTGCTGTACGTGAACGAGAAAATAGACC
GCGAACAAATCTGCAAACAGAGCCCCTCCTGTGTCCTGCACCTGGAGGTCTTTCTGGAGAACCCCCTGGAGCTGTTCCAGGTGGAGATCGAGGTGCTGGACATTAATGACAACCCCCCCTCTTTCCCG
GAGCCAGACCTGACGGTGGAAATCTCTGAGAGCGCCACGCCAGGCACTCGCTTCCCCTTGGAGAGCGCATTCGACCCAGACGTGGGCACCAACTCCTTGCGCGACTACGAGATCACCCCCAACAGCTA
CTTCTCCCTGGACGTGCAGACCCAGGGGGATGGCAACCGATTCGCTGAGCTGGTGCTGGAGAAGCCACTGGACCGAGAGCAGCAAGCGGTGCACCGCTACGTGCTGACCGCGGTGGACGGAGGAGGTG
GGGGAGGAGTAGGAGAAGGAGGGGGAGGTGGCGGGGGAGCAGGCCTGCCCCCCCAGCAGCAGCGCACCGGCACGGCCCTACTCACCATCCGAGTGCTGGACTCCAATGACAATGTGCCCGCTTTCGAC
CAACCCGTCTACACTGTGTCCCTACCAGAGAACTCTCCCCCAGGCACTCTCGTGATCCAGCTCAACGCCACCGACCCGGACGAGGGCCAGAACGGTGAGGTCGTGTACTCCTTCAGCAGCCACATTTC
GCCCCGGGCGCGGGAGCTTTTCGGACTCTCGCCGCGCACTGGCAGACTGGAGGTAAGCGGCGAGTTGGACTATGAAGAGAGCCCAGTGTACCAAGTGTACGTGCAAGCCAAGGACCTGGGCCCCAACG
CCGTGCCTGCGCACTGCAAGGTGCTAGTGCGAGTACTGGATGCTAATGACAACGCGCCAGAGATCAGCTTCAGCACCGTGAAGGAAGCGGTGAGTGAGGGCGCGGCGCCCGGCACTGTGGTGGCCCTT
TTCAGCGTGACTGACCGCGACTCAGAGGAGAATGGGCAGGTGCAGTGCGAGCTACTGGGAGACGTGCCTTTCCGCCTCAAGTCTTCCTTTAAGAATTACTACACCATCGTTACCGAAGCCCCCCTGGA
CCGAGAGGCGGGGGACTCCTACACCCTGACTGTAGTGGCTCGGGACCGGGGCGAGCCTGCGCTCTCCACCAGTAAGTCGATCCAGGTACAAGTGTCGGATGTGAACGACAACGCGCCGCGTTTCAGCC
AGCCGGTCTACGACGTGTATGTGACTGAAAACAACGTGCCTGGCGCCTACATCTACGCGGTGAGCGCCACCGACCGGGATGAGGGCGCCAACGCCCAGCTTGCCTACTCTATCCTCGAGTGCCAGATC
CAGGGCATGAGCGTCTTCACCTACGTTTCTATCAACTCTGAGAACGGCTACTTGTACGCCCTGCGCTCCTTCGACTATGAGCAGCTGAAGGACTTCAGTTTTCAGGTGGAAGCCCGGGACGCTGGCAG
CCCCCAGGCGCTGGCTGGTAACGCCACTGTCAACATCCTCATAGTGGATCAAAATGACAACGCCCCTGCCATCGTGGCGCCTCTACCAGGGCGCAACGGGACTCCAGCGCGTGAGGTGCTGCCCCGCT
CGGCGGAGCCGGGTTACCTGCTCACCCGCGTGGCCGCCGTGGACGCGGACGACGGCGAGAACGCCCGGCTCACTTACAGCATCGTGCGTGGCAACGAAATGAACCTCTTTCGCATGGACTGGCGCACC
GGGGAGCTGCGCACAGCACGCCGAGTCCCGGCCAAGCGCGACCCCCAGCGGCCTTATGAGCTGGTGATCGAGGTGCGCGACCATGGGCAGCCGCCCCTTTCCTCCACCGCCACCCTGGTGGTTCAGCT
GGTGGATGGCGCCGTGGAGCCCCAGGGCGGGGGCGGGAGCGGAGGCGGAGGGTCAGGAGAGCACCAGCGCCCCAGTCGCTCTGGCGGCGGGGAAACCTCGCTAGACCTCACCCTCATCCTCATCATCG
CGTTGGGCTCGGTGTCCTTCATCTTCCTGCTGGCCATGATCGTGCTGGCCGTGCGTTGCCAAAAAGAGAAGAAGCTCAACATCTATACTTGTCTGGCCAGCGATTGCTGCCTCTGCTGCTGCTGCTGC
GGTGGCGGAGGTTCGACCTGCTGTGGCCGCCAAGCCCGGGCGCGCAAGAAGAAACTCAGCAAGTCAGACATCATGCTGGTGCAGAGCTCCAATGTACCCAGTAACCCGGCCCAGGTGCCGATAGAGGA
GTCCGGGGGCTTTGGCTCCCACCACCACAACCAGAATTACTGCTATCAGGTATGCCTGACCCCTGAGTCCGCCAAGACCGACCTGATGTTTCTTAAGCCCTGCAGCCCTTCGCGGAGTACGGACACTG
AGCACAACCCCTGCGGGGCCATCGTCACCGGTTACACCGACCAGCAGCCTGATATCATCTCCAACGGAAGCATTTTGTCCAACGAGACTAAACACCAGCGAGCAGAGCTCAGCTATCTAGTTGACAGA
CCTCGCCGAGTTAACAGTTCTGCATTCCAGGAAGCCGACATAGTAAGCTCTAAGGACAGTGGTCATGGAGACAGTGAACAGGGAGATAGTGATCATGATGCCACCAACCGTGCCCAGTCAGCTGGTAT
GGATCTCTTCTCCAATTGCACTGAGGAATGTAAAGCTCTGGGCCACTCAGATCGGTGCTGGATGCCTTCTTTTGTCCCTTCTGATGGACGCCAGGCTGCTGATTATCGCAGCAATCTGCATGTTCCTG
GCATGGACTCTGTTCCAGACACTGAGGTGTTTGAAACTCCAGAAGCCCAGCCTGGGGCAGAGCGGTCCTTTTCCACCTTTGGCAAAGAGAAGGCCCTTCACAGCACTCTGGAGAGGAAGGAGCTGGAT
GGACTGCTGACTAATACGCGAGCGCCTTACAAACCACCATATTTGAAGCTATTGTGGAGGCAGCTATGTGGAGAGACACATGTGGCACAAGATCAAGGGCTGTCAACAACCACATGAGTGAGCTTGGA
AACAGACTCCCAAGTTGAGCATTCAGATGAGACCACAGCCCCTGCTGACAGTTTGACTGCAACCTTTGAGAGTCCTTAGCCAGAGGCACCCAGTTAAGCTGCACTAAAATTTTTGAACCACACAGATT
GTGAGATAATAAATATTTGTGGTTTTATGTTGTGAGGTTTTGGGGTATATTGCCATGTGGCAATAAATAGTTAATACATTATGTAGGTGAGAATCCTATTGTCTGATACAGTAATATGAAGTATTGAT
TTTTCTGGTGTGATGTGGCCATTTTCAAAACCAATATGTATAATGTACACACCCTGTTGCTTTACCTTCGTCTTCAATTTTCAGTTCTTGCTTACTCCTCTTTCCCTGACCTTGCACACAAAAAATCA
TCCCCACTATTTTTGGGATTGATCTACTGGCTTAAAAAAAATAAAGCTGTACTTACCAGATGAAA

hide sequence

RefSeq Acc Id:

XM_054350597 ⟹ XP_054206572

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	4	136,472,535 - 136,531,845 (+)	NCBI


Protein RefSeqs	NP_065866	(Get FASTA)	NCBI Sequence Viewer
	NP_116586	(Get FASTA)	NCBI Sequence Viewer
	XP_011530452	(Get FASTA)	NCBI Sequence Viewer
	XP_054206572	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAI11561	(Get FASTA)	NCBI Sequence Viewer
	AAK21987	(Get FASTA)	NCBI Sequence Viewer
	AAY41018	(Get FASTA)	NCBI Sequence Viewer
	AHW56553	(Get FASTA)	NCBI Sequence Viewer
	AHW56554	(Get FASTA)	NCBI Sequence Viewer
	BAA92638	(Get FASTA)	NCBI Sequence Viewer
	BAB14940	(Get FASTA)	NCBI Sequence Viewer
	BAG37004	(Get FASTA)	NCBI Sequence Viewer
	CAB75667	(Get FASTA)	NCBI Sequence Viewer
	EAX05151	(Get FASTA)	NCBI Sequence Viewer
	EAX05152	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000264360
	ENSP00000264360.4
	ENSP00000480512
	ENSP00000480512.1
GenBank Protein	Q9P2E7	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_116586 ⟸ NM_032961
- Peptide Label:	isoform 1 precursor
- UniProtKB:	Q4W5F6 (UniProtKB/Swiss-Prot), Q96SF0 (UniProtKB/Swiss-Prot), Q9P2E7 (UniProtKB/Swiss-Prot), X5D999 (UniProtKB/TrEMBL), Q14DV7 (UniProtKB/TrEMBL)
- Sequence:	show sequence MIVLLLFALLWMVEGVFSQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYLDLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLT VEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDREQQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYT VSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEESPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTD RDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKSIQVQVSDVNDNAPRFSQPVYDVYVTENNVPGAYIYAVSATDRDEGANAQLAYSILECQIQGMSV FTYVSINSENGYLYALRSFDYEQLKDFSFQVEARDAGSPQALAGNATVNILIVDQNDNAPAIVAPLPGRNGTPAREVLPRSAEPGYLLTRVAAVDADDGENARLTYSIVRGNEMNLFRMDWRTGELRT ARRVPAKRDPQRPYELVIEVRDHGQPPLSSTATLVVQLVDGAVEPQGGGGSGGGGSGEHQRPSRSGGGETSLDLTLILIIALGSVSFIFLLAMIVLAVRCQKEKKLNIYTCLASDCCLCCCCCGGGGS TCCGRQARARKKKLSKSDIMLVQSSNVPSNPAQVPIEESGGFGSHHHNQNYCYQVCLTPESAKTDLMFLKPCSPSRSTDTEHNPCGAIVTGYTDQQPDIISNGSILSNETKHQRAELSYLVDRPRRVN SSAFQEADIVSSKDSGHGDSEQGDSDHDATNRAQSAGMDLFSNCTEECKALGHSDRCWMPSFVPSDGRQAADYRSNLHVPGMDSVPDTEVFETPEAQPGAERSFSTFGKEKALHSTLERKELDGLLTN TRAPYKPPYLTRKRIC hide sequence

RefSeq Acc Id:	NP_065866 ⟸ NM_020815
- Peptide Label:	isoform 2 precursor
- UniProtKB:	Q14DV7 (UniProtKB/TrEMBL)
- Sequence:	show sequence MIVLLLFALLWMVEGVFSQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYL DLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDRE QQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEE SPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKS IQVQVSDVNDNAPRFSQPVYDVYVTENNVPGAYIYAVSATDRDEGANAQLAYSILECQIQGMSVFTYVSINSENGYLYALRSFDYEQLKDFSFQVEARDAGSPQALAGNATVNILIVDQNDNAPAIVA PLPGRNGTPAREVLPRSAEPGYLLTRVAAVDADDGENARLTYSIVRGNEMNLFRMDWRTGELRTARRVPAKRDPQRPYELVIEVRDHGQPPLSSTATLVVQLVDGAVEPQGGGGSGGGGSGEHQRPSR SGGGETSLDLTLILIIALGSVSFIFLLAMIVLAVRCQKEKKLNIYTCLASDCCLCCCCCGGGGSTCCGRQARARKKKLSKSDIMLVQSSNVPSNPAQVPIEESGGFGSHHHNQNYCYQVCLTPESAKT DLMFLKPCSPSRSTDTEHNPCGAIVTGYTDQQPDIISNGSILSNEVRLKRKDHHLSSPPSESLL hide sequence

RefSeq Acc Id:	XP_011530452 ⟸ XM_011532150
- Peptide Label:	isoform X1
- UniProtKB:	Q14DV7 (UniProtKB/TrEMBL)
- Sequence:	show sequence MIVLLLFALLWMVEGVFSQLHYTVQEEQEHGTFVGNIAEDLGLDITKLSARGFQTVPNSRTPYL DLNLETGVLYVNEKIDREQICKQSPSCVLHLEVFLENPLELFQVEIEVLDINDNPPSFPEPDLTVEISESATPGTRFPLESAFDPDVGTNSLRDYEITPNSYFSLDVQTQGDGNRFAELVLEKPLDRE QQAVHRYVLTAVDGGGGGGVGEGGGGGGGAGLPPQQQRTGTALLTIRVLDSNDNVPAFDQPVYTVSLPENSPPGTLVIQLNATDPDEGQNGEVVYSFSSHISPRARELFGLSPRTGRLEVSGELDYEE SPVYQVYVQAKDLGPNAVPAHCKVLVRVLDANDNAPEISFSTVKEAVSEGAAPGTVVALFSVTDRDSEENGQVQCELLGDVPFRLKSSFKNYYTIVTEAPLDREAGDSYTLTVVARDRGEPALSTSKS IQVQVSDVNDNAPRFSQPVYDVYVTENNVPGAYIYAVSATDRDEGANAQLAYSILECQIQGMSVFTYVSINSENGYLYALRSFDYEQLKDFSFQVEARDAGSPQALAGNATVNILIVDQNDNAPAIVA PLPGRNGTPAREVLPRSAEPGYLLTRVAAVDADDGENARLTYSIVRGNEMNLFRMDWRTGELRTARRVPAKRDPQRPYELVIEVRDHGQPPLSSTATLVVQLVDGAVEPQGGGGSGGGGSGEHQRPSR SGGGETSLDLTLILIIALGSVSFIFLLAMIVLAVRCQKEKKLNIYTCLASDCCLCCCCCGGGGSTCCGRQARARKKKLSKSDIMLVQSSNVPSNPAQVPIEESGGFGSHHHNQNYCYQVCLTPESAKT DLMFLKPCSPSRSTDTEHNPCGAIVTGYTDQQPDIISNGSILSNETKHQRAELSYLVDRPRRVNSSAFQEADIVSSKDSGHGDSEQGDSDHDATNRAQSAGMDLFSNCTEECKALGHSDRCWMPSFVP SDGRQAADYRSNLHVPGMDSVPDTEVFETPEAQPGAERSFSTFGKEKALHSTLERKELDGLLTNTRAPYKPPYLKLLWRQLCGETHVAQDQGLSTTT hide sequence

Ensembl Acc Id:

ENSP00000480512 ⟸ ENST00000618019

Ensembl Acc Id:

ENSP00000264360 ⟸ ENST00000264360

Protein Domains

Cadherin Cadherin cytoplasmic C-terminal

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9P2E7-F1-model_v2	AlphaFold	Q9P2E7	1-1040	view protein structure

RGD ID:

6868482

Promoter ID:

EPDNEW_H7406

Type:

multiple initiation site

Name:

PCDH10_1

Description:

protocadherin 10

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	4	133,149,294 - 133,149,354	EPDNEW

RGD ID:

6802228

Promoter ID:

HG_KWN:49116

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

K562

Transcripts:

ENST00000394248, NM_032961, UC003IGY.2

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	4	134,289,726 - 134,290,226 (+)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	PCDH10	COSMIC
Ensembl Genes	ENSG00000138650	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000264360	ENTREZGENE
	ENST00000264360.7	UniProtKB/Swiss-Prot
	ENST00000618019	ENTREZGENE
	ENST00000618019.1	UniProtKB/Swiss-Prot
Gene3D-CATH	Cadherins	UniProtKB/Swiss-Prot
GTEx	ENSG00000138650	GTEx
HGNC ID	HGNC:13404	ENTREZGENE
Human Proteome Map	PCDH10	Human Proteome Map
InterPro	Cadherin-like_dom	UniProtKB/Swiss-Prot
	Cadherin-like_sf	UniProtKB/Swiss-Prot
	Cadherin_C	UniProtKB/Swiss-Prot
	Cadherin_CS	UniProtKB/Swiss-Prot
	Cadherin_N	UniProtKB/Swiss-Prot
	Protocadherin/Cadherin-CA	UniProtKB/Swiss-Prot
KEGG Report	hsa:57575	UniProtKB/Swiss-Prot
NCBI Gene	57575	ENTREZGENE
OMIM	608286	OMIM
PANTHER	CADHERIN-87A	UniProtKB/Swiss-Prot
	PTHR24028:SF0	UniProtKB/Swiss-Prot
Pfam	Cadherin	UniProtKB/Swiss-Prot
	Cadherin_2	UniProtKB/Swiss-Prot
	Cadherin_C_2	UniProtKB/Swiss-Prot
PharmGKB	PA32995	PharmGKB
PRINTS	CADHERIN	UniProtKB/Swiss-Prot
PROSITE	CADHERIN_1	UniProtKB/Swiss-Prot
	CADHERIN_2	UniProtKB/Swiss-Prot
SMART	SM00112	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF49313	UniProtKB/Swiss-Prot
UniProt	PCD10_HUMAN	UniProtKB/Swiss-Prot
	Q14DV7	ENTREZGENE, UniProtKB/TrEMBL
	Q4W5F6	ENTREZGENE
	Q96SF0	ENTREZGENE
	Q9NSR3_HUMAN	UniProtKB/TrEMBL
	Q9P2E7	ENTREZGENE
	X5D2R8_HUMAN	UniProtKB/TrEMBL
	X5D999	ENTREZGENE, UniProtKB/TrEMBL
UniProt Secondary	Q4W5F6	UniProtKB/Swiss-Prot
	Q96SF0	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - CTD